Last reviewed · How we verify

Tetracaine Hydrochloride — Competitive Intelligence Brief

Tetracaine Hydrochloride (TETRACAINE) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Ester Local Anesthetic. Area: Neuroscience.

marketed Ester Local Anesthetic Sodium channel protein type 7 subunit alpha Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Tetracaine Hydrochloride (TETRACAINE) — Alcon Labs. Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Tetracaine Hydrochloride TARGET TETRACAINE Alcon Labs marketed Ester Local Anesthetic Sodium channel protein type 7 subunit alpha 2005-01-01
Nesacaine-Mpf CHLOROPROCAINE Fresenius Kabi marketed Ester Local Anesthetic Sodium channel protein type 10 subunit alpha 1955-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Ester Local Anesthetic class)

  1. Alcon Labs · 1 drug in this class
  2. Fresenius Kabi · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tetracaine Hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/tetracaine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: